General Information
Version
1.2
Revision date
2025-06-06
Product name
KRISTA SOP
Product name
KRISTA SOP
Identification on the label/Trade name
Instituto Nacional de Toxicologia
CAS No.
7778-80-5
REACH No
01-2119489441-34
1.2.1 Relevant identified uses
Industrial distribution Industrial USE to formulate fertilisers product mixtures Professional formulation of fertiliser products Professional USE as fertiliser in Greenhouse
Emergency telephone
+34 9 1114 2520, +351 30 880 4750
Icons in SDS
Company Information
company name
Yara Iberian S.A
e-mail address of the competent person responsible for the Safety Data Sheet
yaraiberian@yara.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mono-constituent substance
Signal word
Danger
Hazard statements
H318 Causes serious eye damage.
Prevention
P280 Wear protective gloves and eye protection.
Response
P305 IF IN EYES: P351 Rinse cautiously with water for several minutes. P338 Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER or doctor/physician. EU Regulation (EC) No. Not applicable.
Special packaging requirements
Containers to be fitted with Not applicable. child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the
PBT Substances
P B T
vPvB Substances
vP vB criteria for PBT or vPvB Not N/A Not N/A according to applicable Regulation (EC) No. (Inorganic)
Other hazards which do not result in classification
None known.
Additional information
None.
2.1 Classification of the substance or mixture
Product definition : Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Classification : Eye Dam. 1, H318 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
